Circular No. 16/2018/TT-BYT detailing certain provisions of Decree No. 54/2017/NĐ-CP on practicing pharmacy and selling drugs. This Circular guides the issuance of practice certificates for pharmacists, drug advertising activities, drug promotion, organization and operation of advisory boards for issuing practice certificates, as well as transitional provisions and effectiveness.
적용 범위
The Department of Medicines Management, the Department of Traditional Medicine, the Department of Science, Technology and Training, units under the Ministry of Health, Provincial Departments of Health, relevant agencies, organizations, and individuals.
핵심 사항
- Guidance on issuing practice certificates for pharmacists
- Regulations on drug advertising activities
- Regulations on drug promotion
- Organization and operation of advisory boards for issuing practice certificates for pharmacists
- Transitional provisions and effectiveness
🌐 이 문서의 사회적 영향
- Enhancing the quality of the pharmacy workforce
- Standardizing the process of issuing practice certificates for pharmacists
- Clear regulations on drug advertising activities and promotion
- Strengthening management and supervision of drug-selling establishments
❓ 자주 묻는 질문
What does this Circular replace?
Circular No. 16/2018/TT-BYT replaces Circular No. 13/2009/TT-BYT dated September 1, 2009, issued by the Minister of Health, guiding drug information and advertising activities.
When does this Circular take effect?
Circular No. 16/2018/TT-BYT takes effect from June 1, 2018.
전문
CIRCULAR
Detailed regulations certain provisions on pharmaceutical business under the Drug Law and Decree No. 54/2017/ND-CP dated May 8, 2017 of the Government detailing certain provisions and measures to implement the Drug Law
Pursuant to the Law No. 105/2016/QH13 dated 06 of the Government stipulating the functions, tasks, powers, and organizational structure of4 Pursuant to Decree No. 32/2019/NĐ-CP dated April 10, 2019 of the Government on assigning tasks, procurement or tendering for the supply of products and services using state budget from regular operating expenses;16 on pharmaceuticals;
WHEREAS Decree No. 54/2017/ND-CP dated May 8, 2017 the Government details ofcertain provisions and measures to implement the Drug Law 2017 of the Government stipulates the functions, tasks, powers, and organizational structure of the Ministry of Health;;
Pursuant to Decree No. 75/2017/NĐ-CP dated October 27, 2017 of the Government stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health; the 6 year ing the Director of the
AT THE PROPOSAL OF THE DIRECTOR OF THE QUALITY MANAGEMENT DEPARTMENT;trAdministration of Domestic air passenger transport service on regular basic economy classPharmaceuticals,
The Minister of Health issues this Circular qetails certain provisions on pharmaceutical business under the Drug Law and Decree No. 54/2017/ND-CP dated May 8, 2017 of the Government detailing certain provisions and measures to implement the Drug Law. Article 1. Scope
PART I
GENERAL PROVISIONS
This Circular stipulates detailed regulations on pharmaceutical business, including: đAdjustment
1. Requirements for using language in pharmaceutical practice in Vietnam for foreigners and overseas Vietnamese citizens as provided for in Clause 2, Article 14 of the Drug Law.
2. Notification and public disclosure of the list of persons holding Pharmaceutical Practice Certificates practicing at pharmaceutical business establishments as provided for in Point g, Clause 2, Article 42 of the Drug Law.
3. Activities of establishments engaging in pharmaceutical activities not subject to issuance of a Certificate of Compliance with Conditions for Pharmaceutical Business as provided for in Article 35 of the Drug Law.
4. Sale of medicines listed in the Restricted Retail Medicines List as provided for in Point k, Clause 2, Article 42 of the Drug Law.
5. Additional sale of medicines at pharmacy counters in areas inhabited by ethnic minorities, mountainous regions, islands, and areas with particularly difficult socio-economic conditions as provided for in Point b, Clause 1, Article 48 of the Drug Law.
6. Persons introducing medicines from pharmaceutical business establishments to medical practitioners as provided for in Point b, Clause 6, Article 76 of the Drug Law.
7. Organization and operation of the Advisory Council for Issuing Pharmaceutical Practice Certificates as provided for in Clause 11, Article 6 of Decree No. 54/2017/ND-CP dated May 8, 2017 of the Government detailing certain provisions and measures to implement the Drug Law (hereinafter referred to as Decree No. 54/2017/ND-CP).
This Circular applies to agencies, organizations, and individuals in Vietnam, overseas Vietnamese citizens; foreign organizations and individuals engaged in pharmaceutical practice, pharmaceutical business, or engaging in pharmaceutical activities not subject to issuance of a Certificate of Compliance with Conditions for Pharmaceutical Business in Vietnam.
Article 2. Applicability
REQUIREMENTS FOR LANGUAGE USE
Chapter II
IN PHARMACEUTICAL PRACTICE FOR FOREIGNERS AND OVERSEAS VIETNAMESE CITIZENS
Article 3. Requirements for language use in pharmaceutical practice
1. The person responsible for pharmaceutical matters at retail drug stores and the clinical pharmacist at medical examination and treatment facilities who are foreigners and overseas Vietnamese citizens must be recognized as proficient in Vietnamese, and if they are not proficient in Vietnamese, they must register their language of use and have an interpreter available as provided for in Article 5 of this Circular.
2. Foreigners and overseas Vietnamese citizens who have not been recognized as proficient in Vietnamese in pharmaceutical practice must indicate "interpreter required during practice" on their Pharmaceutical Practice Certificate. When practicing pharmaceuticals, the application for a Certificate of Compliance with Conditions for Pharmaceutical Business must include a contract with an interpreter meeting the requirements set out in Clauses 1 and 2 of Article 5 of this Circular.
Criteria for recognizing foreigners and overseas Vietnamese citizens as proficient in Vietnamese or proficient in another language in pharmaceutical practice
Article 41. A person practicing pharmaceuticals is recognized as proficient in Vietnamese when they are tested and certified as such by an educational institution specified in Article 6 of this Circular, except in cases provided for in Clause 3 of this Article.2. If a practitioner registers a language other than their native language or Vietnamese for pharmaceutical practice, they must be tested and certified as proficient in that language by an educational institution specified in Article 6 of this Circular, except in cases provided for in Clause 3 of this Article. The language registered for pharmaceutical practice may be one of the following: English, French, Russian, Chinese, Japanese, and Korean.3. A person practicing pharmaceuticals is recognized as proficient in Vietnamese or proficient in another language in pharmaceutical practice without testing if they fall into one of the following categories: a) Hold a diploma in a pharmaceutical or traditional medicine program at the associate degree level or higher issued by a legitimate educational institution in Vietnam or abroad where the language of instruction was Vietnamese or the language registered for pharmaceutical practice as provided for in Clause 2 of this Article; b) Hold a certificate of completion of a pharmaceutical or traditional medicine training course lasting twelve months or more where the language of instruction was Vietnamese or the language registered for pharmaceutical practice as provided for in Clause 2 of this Article; c) Hold a bachelor's degree in a pharmaceutical or traditional medicine program issued by a legitimate educational institution in Vietnam or abroad where the language of instruction was Vietnamese or the language registered for pharmaceutical practice as provided for in Clause 2 of this Article. Diplomas and certificates specified in Points a and b of this Clause must be issued within five years prior to the date of submission of the application.
Criteria for recognizing interpreters as qualified for pharmaceutical practice
1. An interpreter is recognized as qualified for pharmaceutical practice when they are tested and certified by an educational institution specified in Article 6 of this Circular, except in cases provided for in Clause 2 of this Article.
2. An interpreter is recognized as qualified for pharmaceutical practice without testing if they fall into one of the following categories:
a) Hold a diploma in a pharmaceutical or traditional medicine program at the associate degree level or higher issued by a legitimate educational institution in Vietnam or abroad where the language of instruction was the language they intend to interpret for pharmaceutical practice.
b) Hold a certificate from completing a specialized training course in medicine, pharmacy, or traditional medicine with a duration of 12 (twelve) months or more, where the language used during the training is Vietnamese or the language that the practitioner registers to use in their pharmacy practice as stipulated in Clause 2 of this Article;
c) Possess a bachelor's degree in medicine, pharmacy, or traditional medicine issued by a legitimate educational institution in Vietnam or abroad, where the language used during the training is Vietnamese or the language that the practitioner registers to use in their pharmacy practice as stipulated in Clause 2 of this Article;
The certificates and certificates specified in points a and b of this clause must be issued within a period not exceeding 05 (five) years, calculated from the date of submitting the application;
Article 5Criteria for recognizing individuals as having sufficient proficiency in interpreting for pharmacy practice;
1. An individual is recognized as having sufficient proficiency in interpreting for pharmacy practice when they are tested and certified by the educational institution specified in Article 6 of this Circular, except in cases stipulated in Clause 2 of this Article;
2. An interpreter is recognized as having sufficient proficiency in interpreting for pharmacy practice without undergoing testing if they fall under any of the following circumstances:
a) Hold a diploma in a specialized associate degree in medicine, pharmacy, or higher, issued by a legitimate educational institution in Vietnam or abroad, where the language used during the training is the language that the interpreter registers to interpret;
b) Hold a certificate from completing a specialized medical or pharmaceutical training course lasting twelve (12) months or more, with the language used during the training being the language for which the interpreter registers to interpret;
c) Possess a diploma in a specialized medical or pharmaceutical field at the intermediate level or higher and a bachelor's degree in a foreign language that corresponds to the language for which the interpreter registers to interpret.
The certificates and licenses specified in points a and b of Clause 2, Article 4 of this Decree must be issued within no more than five (5) years, calculated from the date of submission of the application.
3. An interpreter may only provide interpreting services for one pharmacist at the same time while the pharmacist is practicing pharmacy.
Article 6. Educational institutions are authorized to conduct examinations and recognize proficiency in Vietnamese or fluency in another language or sufficient interpreting skills in pharmacy practice
Educational institutions are authorized to conduct examinations and recognize proficiency in Vietnamese or fluency in another language or sufficient interpreting skills in pharmacy practice (hereinafter referred to as educational institutions conducting language examinations in pharmacy practice) when meeting the following requirements:
1. Being a specialized university in medicine or pharmacy in Vietnam.
2. Having a department or subject in a foreign language specified in Clause 2, Article 4 of this Circular and meeting the criteria for evaluating Vietnamese language proficiency in specialized fields as stipulated in Circular No. 17/2015/TT-BGDĐT dated September 1, 2015, issued by the Minister of Education and Training on the Vietnamese language proficiency framework for foreigners.
3. Having a bank of examination questions to conduct examinations and recognize proficiency in Vietnamese or fluency in another language or sufficient interpreting skills in pharmacy practice.
Article 7. Documents, This Decree regulates the implementation of electronic linkage for a group of administrative procedures: Registration of establishment of business households - issuance of Certificate of Eligibility for Security and Public Order Conditions - issuance of Certificate of Permission for Eligibility to Operate Karaoke Services (hereinafter referred to as the Electronic Linkage Administrative Procedure for Issuance of Certificate of Permission for Eligibility to Operate Karaoke Services); responsibilities of agencies, organizations, business households, and individuals in implementing administrative procedures. announcing language 教育 including computer-based multiple choice tests education institutions Industry and pharmacy practice
1. Documents:
a) A notice of the educational institution conducting language examinations in pharmacy practice according to Model No. 01 prescribed in Appendix I attached to this Circular;
b) A certified copy of documents proving the establishment and operation of the educational institution;
c) Documents proving the existence of a department or subject in a foreign language as specified in Clause 2, Article 6 of this Circular and a list of full-time faculty members of the department or subject in a foreign language;
d) A bank of examination questions used to examine and recognize proficiency in Vietnamese or fluency in another language or sufficient interpreting skills in pharmacy practice for at least one of the languages specified in Clause 2, Article 4 of this Circular.
2. In cases where an educational institution has been announced as meeting the conditions for conducting examinations and recognizing proficiency in Vietnamese or fluency in another language or sufficient interpreting skills in pharmacy practice and requests to add additional languages specified in Clause 2, Article 4 of this Circular for examination and recognition, the application shall be made in accordance with points a, c, and d of Clause 1 of this Article.
3. Procedures:
a) The educational institution submits one set of application documents for announcement in accordance with Clauses 1 and 2 of this Article to the Ministry of Health (Science and Technology Department);
b) The Ministry of Health (Science and Technology Department) issues to the educational institution a Receipt of Application Documents according to Model No. 02 prescribed in Appendix I attached to this Circular;
c) Within five (5) working days from the date recorded on the Receipt of Application Documents, the Ministry of Health (Science and Technology Department) is responsible for announcing the language examination institution in pharmacy practice on the Ministry of Health’s Electronic Information Portal. If not announced, a written response explaining the reasons must be provided.
Article 8. Cases of revoking the announcement of educational institutions conducting language examinations in pharmacy practice
1. Ceasing operations of language examinations and recognitions in pharmacy practice.
2. Not meeting one of the requirements stipulated in Article 6 of this Circular.
3. Falsifying documents in the application for announcing an educational institution conducting language examinations in pharmacy practice.
Article 9. Procedure for Revoking the Announcement of Language Testing Educational Institutions in the Practice of Pharmacy
1. Within 05 (five) working days from the date of the conclusion of the competent authority containing a recommendation to revoke the announcement or receiving a request to revoke the announcement related to the case stipulated in Article 8 of this Circular, the Ministry of Health (Department of Science, Technology and Training) shall revoke the announcement of language testing educational institutions in the practice of pharmacy under its management; if not revoking the announcement, it must provide a response in writing to the organization or individual making the request to revoke and clearly state the reasons.
2. Within 05 (five) working days from the date of issuing the decision to revoke the announcement of language testing educational institutions in the practice of pharmacy, the Ministry of Health (Department of Science, Technology and Training) shall be responsible for:
a) Publishing the decision to revoke the announcement of language testing educational institutions in the practice of pharmacy on the Ministry of Health's Electronic Information Portal and sending this decision to all Provincial Health Departments nationwide;
b) Updating information on the revocation of the announcement of language testing educational institutions in the practice of pharmacy on the Ministry of Health's Electronic Information Portal.
Article 10. Documents, This Decree regulates the implementation of electronic linkage for a group of administrative procedures: Registration of establishment of business households - issuance of Certificate of Eligibility for Security and Public Order Conditions - issuance of Certificate of Permission for Eligibility to Operate Karaoke Services (hereinafter referred to as the Electronic Linkage Administrative Procedure for Issuance of Certificate of Permission for Eligibility to Operate Karaoke Services); responsibilities of agencies, organizations, business households, and individuals in implementing administrative procedures. requesting examination and recognition of proficiency in Vietnamese or another language or sufficient translation level in pharmacy practice
1. The application dossier for examination and recognition of language proficiency in the practice of pharmacy includes:
a) An application form for examination and recognition of language proficiency in the practice of pharmacy according to Form No. 03 prescribed in Appendix I attached to this Circular;
b) A certified copy of the identity card or citizen identification card or passport or personal identification number or other equivalent document still valid;
c) Two color photographs measuring 04 cm x 06 cm taken against a white background within a period not exceeding six months, calculated from the date of submission of the dossier.
2. Examination and Recognition Procedures:
a) The applicant sends one set of the dossier prescribed in Clause 1 of this Article to the announced language testing educational institution specified in Point c, Clause 3, Article 7 of this Circular;
b) Within 30 days from the date of receipt of complete and valid dossiers, the language testing educational institution issues a certificate according to Form No. 04 prescribed in Appendix I attached to this Circular for cases stipulated in Clauses 1 and 2, Article 4, and Clause 1, Article 5 of this Circular. If a certificate is not issued, a written response must be provided with clear reasons stated.
Within 03 (three) working days from the date of examination results, the educational institution must publicly post the examination results.
3. The application dossier for recognition of proficiency in Vietnamese or another language or sufficient translation level in the practice of pharmacy includes:
a) An application form for recognition of proficiency in Vietnamese or another language or sufficient translation level in the practice of pharmacy according to Form No. 05 prescribed in Appendix I attached to this Circular;
b) The documents and photographs specified in Points b and c of Clause 1 of this Article;
c) A certified copy of the diploma or certificate prescribed in Clause 3, Article 4 of this Circular for cases requesting recognition of proficiency in Vietnamese or another language for the practice of pharmacy; and the diploma or certificate prescribed in Clause 2, Article 5 of this Circular for applicants requesting recognition of sufficient translation level in the practice of pharmacy.
4. Recognition Procedures:
a) The applicant sends one set of the dossier prescribed in Clause 3 of this Article to the announced language testing educational institution specified in Point c, Clause 3, Article 7 of this Circular;
b) Within 10 working days from the date of receipt of complete and valid dossiers, the educational institution issues a certificate according to Form No. 04 prescribed in Appendix I attached to this Circular for cases stipulated in Clause 3, Article 4, and Clause 2, Article 5 of this Circular. If a certificate is not issued, a written response must be provided with clear reasons stated.
Within 03 (three) working days from the date of recognition results, the educational institution must publicly post the recognition results.
Chapter III
ANNOUNCEMENT AND PUBLIC DISCLOSURE LIST
INSPECTOR PRACTICE OF PHARMACY
Article 11. Notificationof the list of persons holding a Pharmaceutical Practice Certificate currently practicing at the facility to the competent authority Within thirty (30) days from the date of commencement of operations or any change in the personnel holding a Pharmaceutical Practice Certificate currently practicing, the pharmaceutical business establishment must notify the Department of Health of the province or centrally governed city (hereinafter referred to as the Department of Health) where the pharmaceutical business establishment operates of the list of persons holding a Pharmaceutical Practice Certificate currently practicing at the establishment, providing information according to Form No. 06 prescribed in Appendix I attached hereto, along with an electronic file or updating online in accordance with the guidance of the Department of Health.
Article 12. Public Disclosure
of the list of persons holding a Pharmaceutical Practice Certificate Within five (5) working days from the date of receipt of the list of persons holding a Pharmaceutical Practice Certificate currently practicing at the establishment operating within its jurisdiction, the Department of Health shall be responsible for publicly disclosing on the Department of Health's Electronic Information Portal the list of persons holding a Pharmaceutical Practice Certificate in accordance with Article 11 of this Circular.
ACTIVITIES OF ESTABLISHMENTS ENGAGED IN PHARMACEUTICAL ACTIVITIES
Chapter IV
NOT SUBJECT TO ISSUANCE OF A LICENSE FOR LEGAL BUSINESS OPERATIONS
General provisions on establishments engaged in pharmaceutical activities not for commercial purposes
Article 13. 1. An establishment engaged in pharmaceutical activities not for commercial purposes is an entity that does not register its operations under the Enterprise Law, engaging in pharmaceutical activities as stipulated in Clause 2 of this Article, including the following entities: a) Public service units;
b) Establishments belonging to armed forces participating in service provision under self-financing mechanisms or pricing regulations set by the Government, excluding cases specified in Point d, Clause 1, Article 35 of the Medicine Law;
c) Pharmacy departments of medical examination and treatment facilities; vaccine and medicine storage warehouses of expanded immunization facilities.
2. Pharmaceutical activities not for commercial purposes include production, compounding, processing, storage, transportation, distribution, testing, and clinical trials of medicines and raw materials for medicines.
3. The assessment of compliance with Good Practices for establishments engaged in pharmaceutical activities not for commercial purposes shall be carried out in accordance with the regulations on Good Practices issued by the Minister of Health. Establishments engaged in pharmaceutical activities not for commercial purposes shall implement Good Practices in accordance with the timeline set forth in Article 142 of Decree No. 54/2017/NĐ-CP.
Article 14. Documents and Procedures for Announcing Establishments Engaged in Retail Pharmacy Operations
1. Documents for announcing establishments engaged in retail pharmacy operations
a) Declaration of an establishment engaged in retail pharmacy operations according to Form No. 07 prescribed in Appendix I attached hereto;
b) Copy of the Decision on Establishment or Investment Certificate or Business Registration Certificate of the establishment, certified and stamped by the establishment;
c) Certified copy of the primary pharmaceutical qualification or higher of the person responsible for professional matters;
d) List of medicines intended to be sold at the pharmacy counter. This list must be within the list of medicines allowed to be sold at the pharmacy counter as prescribed in Appendix II attached hereto;
đ) Photographs of the medicine storage cabinets, counters, and shelves;
e) Quality control and monitoring procedures: quality of medicines; import and export of medicines by the establishment.
2. Procedures for announcing establishments engaged in retail pharmacy operations
a) Prior to commencing operations, an establishment engaged in retail pharmacy operations shall submit directly or send via postal mail one set of documents for announcing an establishment engaged in retail pharmacy operations as stipulated in Clause 1 of this Article to the Department of Health where the establishment is located;
b) Upon receiving the documents, the Department of Health shall issue a Receipt for Submission of Documents for Announcement to the establishment engaged in retail pharmacy operations according to Form No. 02 prescribed in Appendix I attached hereto;
c) Within five (5) working days from the date recorded on the Receipt for Submission of Documents for Announcement, the Department of Health shall be responsible for publicly disclosing on the Department of Health's Electronic Information Portal the list of establishments engaged in retail pharmacy operations meeting the conditions. In case of non-disclosure, a written response stating the reasons must be provided.
b) When receiving the application, the Department of Health issues to the business entity operating a pharmaceutical display shelf a Receipt for Application Submission according to Form No. 02 as prescribed in Appendix I attached to this Circular;
c) Within 05 (five) working days from the date recorded on the Receipt for Application Submission, the Department of Health is responsible for publishing on its Electronic Information Website the list of business entities operating a pharmaceutical display shelf that meet the conditions. In case of non-publication, a written response must be provided stating the reasons;
Article 15. Cases for Revoking the Announcement of Business Establishments with Pharmacy Shelves
1. Termination of the operation of pharmacy shelves or termination of the operation of business establishments with pharmacy shelves.
2. Failure to meet one of the requirements for business establishments with pharmacy shelves stipulated in point b, Clause 2, Article 35 of the Medicine Law.
3. The content of the announcement of business establishments with pharmacy shelves is beyond the authority or contains content contrary to the law.
4. Forgery of documents in the announcement file of business establishments with pharmacy shelves.
5. Not operating continuously for 12 (twelve) months without notifying the Department of Health where the establishment is located.
Article 16. Procedures for Revoking the Announcement of Business Establishments with Pharmacy Shelves
1. Within 05 (five) working days from the date of the conclusion of the competent authority in which it recommends revocation of the announcement or receives a request for revocation related to the cases specified in Article 15 of this Circular, the Department of Health shall revoke the announcement of business establishments with pharmacy shelves under its management jurisdiction; if not revoked, it must provide a written response to the organization or individual requesting revocation and clearly state the reasons.
2. Within 05 (five) working days from the date of issuing the decision to revoke the announcement of business establishments with pharmacy shelves, the Department of Health shall be responsible for:
a) Publishing the decision to revoke the announcement of business establishments with pharmacy shelves on the Department of Health's Electronic Information Portal and sending this decision to the Ministry of Health and other Departments of Health nationwide;
b) Updating information on the revocation of the announcement of business establishments with pharmacy shelves on the Department of Health's Electronic Information Portal.
Article 17. Responsibilities of Business Establishments Engaging in Pharmaceutical Activities Not Subject to Issuance of a Certificate of Eligibility for Pharmaceutical Business
1. Must have a signboard clearly stating the name, address, person responsible for professional matters of the establishment, form and scope of activities, area of operation.
2. Shall be responsible for meeting and maintaining the conditions for the operation of the establishment, the origin of drugs and the quality of drugs supplied by the establishment.
SELLING DRUGS IN THE LIST OF DRUGS WITH RESTRICTED RETAIL SALE
Chapter V
AND ADDITIONAL DRUGS AT THE PHARMACY COUNTER
List of Drugs with Restricted Retail Sale
Article 1Responsibilities of the Project Owner81. Drugs with restricted retail sale are those that require strict monitoring of prescription writing, drug sales according to prescriptions, and usage to ensure safety, efficacy, and prevent drug abuse in treatment, which may lead to drug dependence or non-response when using such drugs or other drugs.
2. The list of drugs with restricted retail sale is specified in Appendix III attached to this Circular.
Selling Drugs in the List of Restricted Retail Sale
Article 19. BBased on the disease structure of the locality, the Department of Health issues a document allowing the retail sale of some drugs in the List of Drugs with Restricted Retail Sale as prescribed in Article 55 of Decree No. 54/2017/NĐ-CP. The disease structure of the locality is determined based on health statistics yearbooks, surveys, and scientific studies that have been published.
Additional
Article 20. BThis Circular takes effect from August 1, 2022./. selling drugs at the pharmacy counter in ethnic minority areas, mountainous regions, islands, and areas with extremely difficult socio-economic conditions in Based on the disease structure of the locality determined in accordance with Article 19 of this Circular, the Department of Health issues a document allowing pharmacies in ethnic minority areas, mountainous regions, islands, and areas with extremely difficult socio-economic conditions to sell additional prescription drugs not included in the Essential Medicines List.
PERSONS INTRODUCING DRUGS
CHAPTER VI
FOR PHARMACEUTICAL BUSINESS ESTABLISHMENTS
Requirements for
Article 1u 21. persons introducing drugs 1. Persons introducing drugs are individuals recruited by pharmaceutical business establishments and issued a "Drug Introduction Person" card by the head of the establishment to inform about drugs to medical practitioners.
2. Persons introducing drugs must meet the following requirements:
a) They must have a college degree in medicine or pharmacy or higher;
b) They must be recruited and trained by the pharmaceutical business establishment regarding skills and professional knowledge related to drug introduction activities and pharmaceutical regulations.
3. The following cases are not eligible for recruitment as persons introducing drugs:
a) Individuals currently undergoing criminal prosecution, serving court sentences, or during the period prohibited from practicing their profession or engaging in work related to pharmaceutical activities as per court decisions;
b) Individuals with limited civil capacity.
Article 22
3. Amend Clause 3 Article 2 as follows:Responsibilities of persons introducing drugs1. Must wear the "Drug Introduction Person" card issued by the pharmaceutical business establishment and comply with internal rules established by the medical facility as stipulated in Clause 2, Article 24 of this Circular when introducing drugs. Drug introduction persons can only introduce drugs with the consent of medical practitioners.
2. Introduce drugs that have been permitted for circulation in Vietnam according to the drug list assigned by the pharmaceutical business establishment and only provide information about drugs as recorded on the label, the drug usage guide registered for circulation, or the drug information content confirmed by the competent authority of the Ministry of Health.
3. Present legal documents proving the validity of drug information content as required by the head of the medical facility or medical practitioners.
4. Collect reports on adverse drug reactions and quality-related reports during drug introduction activities to enable the pharmaceutical business establishment to promptly compile and report to the competent authority of the Ministry of Health according to the National Pharmacovigilance Guidelines issued by the Ministry of Health.
5. Shall not engage in the following actions:
a) Providing drug information that does not match the registered or confirmed content at the competent state authority or distributing drug information materials whose content has not been confirmed by the competent state authority;
b) Introducing drugs not assigned by the pharmaceutical business establishment;
c) Using material benefits in any form to influence doctors or drug users to promote prescription writing, drug purchase and sale, and drug use;
d) Introducing or providing drug information inconsistent with the documents stipulated in Clause 3, Article 76 of the Medicine Law.
d) Providing drug information that is inconsistent with the materials prescribed in Clause 3 of Article 76 of the Pharmacy Law;
d) Comparing and introducing their own drugs as better than those of other establishments without accompanying scientific documentation approved by the competent authority to prove;
e) Introducing products that are not drugs;
g) Engaging in activities related to buying, selling, or storing drugs on behalf of medical practitioners;
h) Accessing patients, medical records, prescriptions, discussions, or requesting information related to patients;
i) Distributing drug informational materials to inappropriate recipients not confirmed by the competent authority of the Ministry of Health.
Article 23. Responsibilities of the Head of a Pharmaceutical Business with Drug Promoters
1. Shall be responsible for the activities and information about drugs disseminated by Drug Promoters of the pharmaceutical business.
2. Shall train and instruct employees recruited to perform the role of Drug Promoter to meet the requirements stipulated in Clause 2 of Article 21 of this Circular.
3. Shall provide Drug Promoters with all necessary legal documents and technical materials to ensure that the drug information disseminated by Drug Promoters complies with the provisions of this Circular.
4. Shall issue the "Drug Promoter" card according to Model No. 08 prescribed in Appendix I attached to this Circular to individuals within the establishment who meet the requirements stipulated in Clause 2 of Article 21 of this Circular.
5. Within the latest seven working days from the date of issuing the card, the pharmaceutical business must submit a list of individuals issued the "Drug Promoter" card according to Model No. 09 prescribed in Appendix I attached to this Circular, along with an electronic file or update online the list of individuals issued the "Drug Promoter" card following the guidance of the Department of Health at the Department of Health where the Drug Promoter conducts promotional activities.
In case there are additions or changes to Drug Promoters, the pharmaceutical business must issue additional or changed "Drug Promoter" cards and update the list of added or changed Drug Promoters according to the initial issuance procedures.
6. Shall revoke the "Drug Promoter" card already issued in the following cases:
a) The Drug Promoter terminates the labor contract with the pharmaceutical business;
b) The Drug Promoter ceases to perform the role of Drug Promoter;
c) The Drug Promoter, after being issued the card, falls under one of the circumstances specified in Clause 3 of Article 21 of this Circular;
d) The Drug Promoter violates any of the acts specified in Clause 5 of Article 22 of this Circular.
7. Within the maximum period of seven working days from the date of revoking the card, the pharmaceutical business must submit a list of individuals whose cards have been revoked according to Model No. 10 prescribed in Appendix I attached to this Circular, along with an electronic file or update online the list of individuals whose cards have been revoked following the guidance of the Department of Health at the Department of Health where the Drug Promoter conducts promotional activities.
8. Shall not reissue the "Drug Promoter" card for at least twelve months from the date of revocation for individuals within the establishment who have had their cards revoked under point d of Clause 6 of this Article.
Article 24. Responsibilities of the Head of a Medical Establishment when there are Drug Promoters operating
1. Shall only allow individuals holding the "Drug Promoter" card to conduct promotional activities and distribute drug informational materials that have been permitted for circulation or confirmed by the competent authority of the Ministry of Health.
2. Shall promulgate and organize the implementation of internal regulations specifying the components, location, time, and organization of drug information dissemination to medical practitioners and other relevant provisions to ensure that Drug Promoters conduct promotional activities within the establishment in compliance with the provisions of this Circular.
3. Shall take measures to prevent the act of prescribing or guiding the use of drugs by medical practitioners of the same establishment for profit motives influenced by material, financial, or any other form of inducement from Drug Promoters.
4. Shall immediately suspend the activity of Drug Promoters within the establishment upon discovering that they are not fulfilling their responsibilities as Drug Promoters as stipulated in Article 22 of this Circular.
Article 25. Responsibilities of the Health Department where the person introducing drugs is located
1. Announce or cancel the announcement of the list of persons who have been issued the "Drug Introduction Person" card on the Health Department's Electronic Information Website within seven working days from the date of receipt of the list of persons issued or whose cards were revoked by the pharmaceutical business establishment in accordance with Clause 5 or Clause 7 of Article 23 of this Circular.
2. Direct medical examination and treatment facilities within its jurisdiction to fully and correctly fulfill the responsibilities of the heads of medical examination and treatment facilities as stipulated in Article 24 of this Circular when there is activity of drug introduction persons.
3. Inspect and supervise drug introduction activities; handle violations of drug introduction persons and pharmaceutical business establishments operating drug introduction activities within its jurisdiction to ensure compliance with the regulations on drug introduction set forth in this Circular.
Chapter VII
ORGANIZATION AND ACTIVITIES
OF THE ADVISORY BOARD FOR ISSUING PRACTICE CERTIFICATES IN PHARMACY
Article 26. Establishment of the Advisory Board
1. The Minister of Health issues a decision to establish the Advisory Board for issuing Practice Certificates in Pharmacy through an examination (hereinafter referred to as the Advisory Board for issuing Practice Certificates in Pharmacy under the Ministry of Health).
2. The Director of the Health Department issues a decision to establish the Advisory Board for issuing Practice Certificates in Pharmacy through an application review (hereinafter referred to as the Advisory Board for issuing Practice Certificates in Pharmacy under the Health Department).
Article 27. Composition of the Advisory Board
1. The composition of the Advisory Board for issuing Practice Certificates in Pharmacy under the Health Department must include at least five members, including: Chairman of the Board, Vice-Chairman of the Board, Secretary, and members, specifically: Leaders of the Health Department, representatives of leaders of related specialized departments, representatives of the Pharmaceutical Association, representatives of state management agencies for education, representatives of public higher education institutions according to Clause 3 of this Article, and staff of relevant units under the Health Department.
2. The composition of the Advisory Board for issuing Practice Certificates in Pharmacy under the Ministry of Health must include at least five members, including: Chairman of the Board, Vice-Chairman of the Board, Secretary, and members, specifically: Leaders of the Ministry of Health, Leaders of the Drug Administration, Leaders of the Traditional Medicine and Drugs Administration for cases involving issuance of practice certificates limited to herbal medicine and traditional drugs, Leaders of the Science, Technology and Training Administration, Leaders of the Legal Affairs Department, representatives of the Pharmaceutical Association, representatives of state management agencies for education, representatives of public higher education institutions according to Clause 3 of this Article, and staff of relevant units under the Ministry of Health.
3. In cases where the diploma does not specify the occupational title as provided for in Article 17 of Decree No. 54/2017/NĐ-CP, the Advisory Board for issuing Practice Certificates in Pharmacy must include representatives of state management agencies for education and representatives of public higher education institutions.
4. In cases where the member of the Board is a representative of an organization, it must be the head of the organization or a person designated by the organization to attend.
Article 28. Activities of the Advisory Board for issuing Practice Certificates in Pharmacy
1. The Advisory Board for issuing Practice Certificates in Pharmacy has the responsibility to develop the Operational Regulations of the Advisory Board to submit to the Minister of Health or the Director of the Health Department for approval and implementation after approval.
2. The Advisory Board for issuing Practice Certificates in Pharmacy has the responsibility to advise the issuing agency on the issuance, reissuance, and revocation of Practice Certificates in Pharmacy.
Chapter VIII
IMPLEMENTING PROVISIONS
Article 29. eff lImplementation
b) Decision No. 35/2008/QD-NHNN dated December 16, 2008, of the Governor of the State Bank of Vietnam amending and supplementing certain articles of the regulations on procedures and formalities for implementing changes by credit unions that require approval promulgated under Decision No. 05/2007/QD-NHNN dated January 30, 2007, of the Governor of the State Bank of Vietnam;
2. Circular No. 13/2009/TT-BYT dated September 1, 2009, of the Minister of Health guiding the operation of drug information and advertising activities ceases to be effective from the date this Circular takes effect.
Article 30. Cross-referencing Provisions
In case the regulatory legal documents and provisions cited in this Circular are amended, supplemented, or replaced, they shall be implemented according to the new regulatory legal documents.
Article 311. For applications and files received by competent authorities before the date this Circular takes effect but not yet resolved, such authorities shall continue to process them according to the laws applicable at the time of receipt.
1. From January 1, 2019, pharmacists practicing under Clause 1 of Article 3 of this Circular who were issued a Professional Practice Certificate before this Circular took effect must have an interpreter or meet the language requirements for pharmaceutical practice as stipulated in this Circular when practicing pharmacy.
2. Individuals holding a "Pharmaceutical Promotion Card" issued pursuant to Circular No. 13/2009/TT-BYT dated September 1, 2009, guiding the activities of drug information and advertising, shall continue to promote drugs until the expiration date of their "Pharmaceutical Promotion Card."
3. For applications for a Drug Business Qualification Certificate in accordance with Article 28 of Decree No. 89/2012/NĐ-CP dated October 24, 2012, amending and supplementing certain provisions of Decree No. 79/2006/NĐ-CP dated August 9, 2006, detailing the implementation of certain provisions of the Pharmacy Law, where the original Professional Practice Certificate of the specialized management personnel has been submitted, the agency receiving the application shall return the original Professional Practice Certificate of the specialized management personnel in the following cases:
a) A pharmaceutical business changes its specialized management personnel;
b) A pharmaceutical business ceases operations;
c) An individual submits an application for a Drug Business Qualification Certificate but receives a response from the agency not granting the certificate;
d) The named individual in the Professional Practice Certificate requests the return of the original Professional Practice Certificate that was submitted.
When returning the original Professional Practice Certificate, the agency receiving the application shall be responsible for keeping a copy of the file stamped with confirmation of comparison with the original Professional Practice Certificate and shall establish a Handover Record for the Return of the Original Professional Practice Certificate according to Model No. 11 specified in Appendix I attached to this Circular, with the agency retaining one copy and the recipient of the original Professional Practice Certificate retaining one copy.
Article 32. Responsibility for Implementation
The Department of Medicines Management, the Department of Traditional Medicine Management, the Department of Science, Technology and Training, units under the Ministry of Health, Provincial Departments of Health, agencies, organizations, and individuals related to this matter shall be responsible for implementing this Circular.
Provincial Departments of Health shall strengthen monitoring and inspection of retail pharmacies within their jurisdiction selling drugs listed in the Restricted Retail Sales List as stipulated in this Circular.
During the implementation process, if there are any issues or difficulties, agencies, organizations, and individuals are requested to promptly report them to the Ministry of Health (Department of Medicines Management, Department of Traditional Medicine Management, Department of Science, Technology and Training) for consideration and resolution./.
원본 문서(PDF)
관계도
문서를 클릭하면 열립니다. 빨간 테두리=효력을 변경하는 관계.
번역본
이 문서는 다음 언어로 제공됩니다: